Erratum to: "Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells" (Molecular Therapy (2008) vol. 16 (2011-2021) 10.1038/mt.2008.206);Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells

Molecular Therapy

Volumn 16, Issue 12, 2008, Pages 2011-2021

  Singh, Ankur ^a   Nie, Hui ^a   Ghosn, Bilal ^a   Qin, Hong ^b   Kwak, Larry W ^b   Roy, Krishnendu ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; NAKED DNA; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYMER; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA TRANSFECTION; FEMALE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION;

MUS;

EID: 56749179475     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.247     Document Type: Erratum

References (39)

1. Brooks, DG, Trifilo, MJ, Edelmann, KH, Teyton, L, McGavern, DB and Oldstone, MB (2006). Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309.
2. Ejrnaes, M, Filippi, CM, Martinic, MM, Ling, EM, Togher, LM, Crotty, S et al. (2006). Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203: 2461-2472.
3. de Waal Malefyt, R, Abrams, J, Bennett, B, Figdor, CG and de Vries, JE (1991). Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220.
4. Fiorentino, DF, Zlotnik, A, Vieira, P, Mosmann, TR, Howard, M, Moore, KW et al. (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451.
5. Liu, G, Ng, H, Akasaki, Y, Yuan, X, Ehtesham, M, Yin, D et al. (2004). Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol 34: 1680-1687.
6. Steinbrink, K, Wolfl, M, Jonuleit, H, Knop, J and Enk, AH (1997). Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159: 4772-4780.
7. Tarcha, PJ, Pelisek, J, Merdan, T, Waters, J, Cheung, K, von Gersdorff, K et al. (2007). Synthesis and characterization of chemically condensed oligoethylenimine containing beta-aminopropionamide linkages for siRNA delivery. Biomaterials 28: 3731-3740.
8. Kasturi, SP, Sachaphibulkij, K and Roy, K (2005). Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 26: 6375-6385.
9. Little, SR, Lynn, DM, Ge, Q, Anderson, DG, Puram, SV, Chen, J et al. (2004). Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci USA 101: 9534-9539.
10. O'Hagan, DT, Singh, M, Dong, C, Ugozzoli, M, Berger, K, Glazer, E et al. (2004). Cationic microparticles are a potent delivery system for a HCV DNA vaccine. Vaccine 23: 672-680.
11. Singh, M, Briones, M, Ott, G and O'Hagan, D (2000). Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97: 811-816.
12. Pai Kasturi, S, Qin, H, Thomson, KS, El-Bereir, S, Cha, SC, Neelapu, S et al. (2006). Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J Control Release 113: 261-270.
13. Singh, M, Ott, G, Kazzaz, J, Ugozzoli, M, Briones, M, Donnelly, J et al. (2001). Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA. Pharm Res 18: 1476-1479.
14. Xie, H, Gursel, I, Ivins, BE, Singh, M, O'Hagan, DT, Ulmer, JB et al. (2005). CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect Immun 73: 828-833.
15. Franco, A, Guidotti, LG, Hobbs, MV, Pasquetto, V and Chisari, FV (1997). Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol 159: 2001-2008.
16. Rosenberg, ES, Billingsley, JM, Caliendo, AM, Boswell, SL, Sax, PE, Kalams, SA et al. (1997). Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278: 1447-1450.
17. Planz, O, Ehl, S, Furrer, E, Horvath, E, Brundler, MA, Hengartner, H et al. (1997). A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci USA 94: 6874-6879.
18. Malanchère-Brès, E, Payette, PJ, Mancini, M, Tiollais, P, Davis, HL and Michel, ML (2001). CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J Virol 75: 6482-6491.
19. Mancini, M, Hadchouel, M, Tiollais, P and Michel, ML (1998). Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization. J Immunol 161: 5564-5570.
20. Sun, H, Pollock, KG and Brewer, JM (2003). Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21: 849-855.
21. Khan, A, Benboubetra, M, Sayyed, PZ, Ng, KW, Fox, S, Beck, G et al. (2004). Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J Drug Target 12: 393-404.
22. Takashima, Y, Saito, R, Nakajima, A, Oda, M, Kimura, A, Kanazawa, T et al. (2007). Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres. Int J Pharm 343: 262-269.
23. Yuan, X, Li, L, Rathinavelu, A, Hao, J, Narasimhan, M, He, M et al. (2006). siRNA drug delivery by biodegradable polymeric nanoparticles. J Nanosci Nanotechnol 6: 2821-2828.
24. Mackey, MF, Barth, RJ, Jr. and Noelle, RJ (11998). The role of CD40/ CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63: 418-428.
25. Jonuleit, H, Schmitt E, Schuler, G, Knop, J and Enk, AH (2000). Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192: 1213-1222.
26. Judge, AD, Sood, V, Shaw, JR, Fang, D, McClintock, K and MacLachian, I (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23: 457-462.
27. Morini, M, Albini, A, Lorusso, G, Moelling, K, Lu, B, Cilli, M et al. (2004). Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy. Gene Ther 11: 284-291.
28. Marques-da-Silva, EA, Coelho, EA, Games, DC, Vilela, MC, Masioli, CZ, Tavares, CA et al. (2005). Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-gamma production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge. Parasitol Res 98: 67-74.
29. Davis, HL, Mancini, M, Michel, ML and Whalen, RG (1996). DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine 14: 910-915.
30. Raz, E, Tighe, H, Sato, Y, Corr, M, Dudler, JA, Roman, M et al. (1996). Preferential induction of a Th1 immune response and inhibition of specific lgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 93: 5141-5145.
31. Woo, PC, Wong, LP, Zheng, BJ and Yuen, KY (2001). Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Vaccine 19: 2945-2954.
32. Zheng, B, Woo, PC, Ng, M, Tsoi, H, Wong, L and Yuen, K (2001). A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model. Vaccine 20: 140-147.
33. Inaba, K, Inaba, M, Romani, N, Aya, H, Deguchi, M, Ikehara, S et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
34. Jackson, JK, Liang, LS, Hunter, WL, Reynolds, M, Sandberg, JA, Springate, C et al. (2002). The encapsulation of ribozymes in biodegradable polymeric matrices. Int J Pharm 243: 43-55.
35. Jiang, Y, Loker, ES and Zhang, SM (2006). In vivo and in vitro knockdown of FREP2 gene expression in the snail Biomphalaria glabrata using RNA interference. Dev Comp Immunol 30: 855-866.
36. Taqvi, S, Dixit, L and Roy, K (2006). Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. J Biomed Mater Res A 79: 689-697.
37. Charo, J and Robbins, PF (2007). Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production. J Leukoc Biol 81: 1297-1302.
38. Karanikas, V, Lodding, J, Maino, VC and McKenzie, IF (2000). Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin Cancer Res 6: 829-837.
39. Pala, P, Hussell, T and Openshaw, PJ (2000). Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243: 107-124.